|
Retinal Dystrophies
|
0.110 |
GeneticVariation
|
group |
BEFREE |
Biallelic variants in TTLL5, encoding a tubulin glutamylase, cause retinal dystrophy.
|
24791901 |
2014 |
|
Cone-Rod Dystrophies
|
0.110 |
AlteredExpression
|
disease |
BEFREE |
Mutations in the polyglutamylase gene TTLL5, expressed in photoreceptor cells and spermatozoa, are associated with cone-rod degeneration and reduced male fertility.
|
28173158 |
2016 |
|
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Here, we review the current biology of the STAMP proteins and how they may be implicated in disease states including cancer and metabolic syndrome.
|
20924965 |
2010 |
|
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Those cancers with the greatest apparent changes in STAMP mRNA were pursued in cultured cancer cell lines.
|
20374646 |
2010 |
|
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Those cancers with the greatest apparent changes in STAMP mRNA were pursued in cultured cancer cell lines.
|
20374646 |
2010 |
|
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Here, we review the current biology of the STAMP proteins and how they may be implicated in disease states including cancer and metabolic syndrome.
|
20924965 |
2010 |
|
Anxiety
|
0.010 |
Biomarker
|
disease |
BEFREE |
Participants (N = 529; 45.9% male; M<sub>age</sub> = 38.23, SD = 13.56) included treatment-seeking smokers who received either a 4-session integrated anxiety-reduction and smoking cessation intervention (Smoking Treatment and Anxiety Management Program; [STAMP]) or a 4-session standard smoking cessation program (SCP).
|
29683703 |
2018 |
|
Anxiety Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Participants (N = 529; 45.9% male; M<sub>age</sub> = 38.23, SD = 13.56) included treatment-seeking smokers who received either a 4-session integrated anxiety-reduction and smoking cessation intervention (Smoking Treatment and Anxiety Management Program; [STAMP]) or a 4-session standard smoking cessation program (SCP).
|
29683703 |
2018 |
|
Crohn Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
We conducted a bioinformatics analysis using the QIIME pipeline and the Calypso, linear discriminant analysis effect size, Phylogenetic Investigation of Communities by Reconstruction of Unobserved States, and STAMP tools on publicly available 16S bacterial rRNA sequencing data from terminal ileum mucosal biopsies of healthy controls and the 3 subphenotypes of Crohn's disease.
|
30346536 |
2019 |
|
Retinal Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Following next-generation sequencing and autozygome-based screening of patients presenting with a peculiar, recessive form of cone-dominated retinopathy, we identified five homozygous variants [p.(Asp594fs), p.(Gln117*), p.(Met712fs), p.(Ile756Phe), and p.(Glu543Lys)] in the polyglutamylase-encoding gene TTLL5, in eight patients from six families.
|
28173158 |
2016 |
|
Malnutrition
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We performed a cross-sectional study comparing three published malnutrition risk screening tools (PYMS, STAMP, and STRONG<sub>kids</sub>), applying them to each inpatient aged 1 month to 17 years over a period of five consecutive weekdays in Helsinki University Hospital, Finland.
|
30909976 |
2019 |
|
Necrotic enteritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further analyses of metagenomeSeq, STAMP, and LEfSe consistently showed significant overgrowth of Clostridium sensu stricto 1 was associated with NE.
|
31150394 |
2019 |
|
Metabolic Syndrome X
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we review the current biology of the STAMP proteins and how they may be implicated in disease states including cancer and metabolic syndrome.
|
20924965 |
2010 |
|
Cone Dystrophy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Novel splice-site mutation in TTLL5 causes cone dystrophy in a consanguineous family.
|
28356705 |
2017 |
|
ovarian neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
These preliminary findings suggest that further studies of STAMP in ovarian cancer may yield insight into ovarian cancer proliferation and may be useful in the development of biomarker panels.
|
20374646 |
2010 |
|
Malignant neoplasm of ovary
|
0.010 |
Biomarker
|
disease |
BEFREE |
These preliminary findings suggest that further studies of STAMP in ovarian cancer may yield insight into ovarian cancer proliferation and may be useful in the development of biomarker panels.
|
20374646 |
2010 |
|
Photoreceptor degeneration
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The Ttll5 mutant mouse develops slow photoreceptor degeneration with early mislocalization of cone opsins, features resembling those of Rpgr-null mice.
|
27162334 |
2016 |
|
Carcinoma, Ovarian Epithelial
|
0.010 |
Biomarker
|
disease |
BEFREE |
These preliminary findings suggest that further studies of STAMP in ovarian cancer may yield insight into ovarian cancer proliferation and may be useful in the development of biomarker panels.
|
20374646 |
2010 |
|
CONE-ROD DYSTROPHY 19
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
CONE-ROD DYSTROPHY 19
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
|
Retinitis Pigmentosa
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
Encephaloclastic Proliferative Vasculopathy
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
CONE-ROD DYSTROPHY 19
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Juvenile-Onset Still Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Juvenile arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |